SPIRIT: Surgeon's Performance in Predicting Postoperative Infections

Sponsor
Leiden University Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05961930
Collaborator
(none)
588
1
10
59.1

Study Details

Study Description

Brief Summary

Post-surgical (bacterial) infections are the most frequent post-surgical complications, including deep or superficial wound infections, urinary tract infections, pneumonia, and even sepsis. Approximately 6.5-25% of all surgical patients will develop any type of bacterial infection. To personalize surgical infection management, (Artificial Intelligence) models are in the making to predict which patients are at high or low risk of developing a post-surgical infection. In order to benchmark these prediction models to the predictive capabilities of surgeons, the investigators aim to investigate the performance of surgeons in predicting the risk of a patient developing (any type) of post-surgical infection within 30 days.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Questionnaire

Detailed Description

A prospective non-interventional study is performed to collect surgeons' predictions on the risk of a patient developing a postoperative infection within 30 days of surgery. Surgeons are asked to fill in a short questionnaire asking about the estimated infection risk. The actual outcome (infection < 30 days of surgery) of a patient will be collected retrospectively after completion of the study. This study will have no effect on standard care: surgical interventions and postoperative care will be carried out according to standard clinical practice. Besides a one-time estimate of the surgeon, immediately after the surgical procedure, no other interventions will be performed and surgical specialists will carry out their normal post-surgical care, including screening and treating (if necessary) their patients for postoperative infections.

Study Design

Study Type:
Observational
Anticipated Enrollment :
588 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Surgeon's Performance in Predicting Postoperative Infections
Actual Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Surgeons estimate of postoperative infection

All surgeons will be asked to fill in a questionnaire, containing 5 questions, pertaining to the estimated risk of postoperative infection (within 30days). Thus there is a single arm and no comparison.

Behavioral: Questionnaire
Surgeons will be asked to fill in a short questionnaire after surgery on risk of postoperative infection

Outcome Measures

Primary Outcome Measures

  1. The discriminative predictive performance of surgeons with respect to estimating the risk of developing (any type) bacterial post-surgical within 30 days of surgery [30 days]

    The primary outcome measure of discrimination are area under the receiving operating characteristic curve (AUROC). Predictions are compared to the occurrence of a postoperative infection requiring treatment, surgical intervention or registration within 30 days of surgery.

  2. The calibration properties of surgeons with respect to estimating the risk of developing (any type) bacterial post-surgical within 30 days of surgery [30 days]

    Calibration plots with slope and intercept

Secondary Outcome Measures

  1. Relationship between the certainty in estimate and the predictive performance of surgeons [30 days]

    Surgeons are questioned on their certainty in the provided estimate

  2. Relationship between patient factors and predicted risk [30 days]

    Surgeons are questioned to indicate for a list of patient factors whether they were of impact to the decision

  3. Predictive performance per surgeons and patients subgroups [30 days]

    Surgeons subgroups are based on specialty, years of experience, level of experience, sex. Patient subgroups include, surgical specialty, age groups, type of surgical procedure, planned or emergency intervention.

  4. Relationship between predicted risk of surgeons and if they perform additional actions [30 days]

    Surgeons are asked to indicate whether they performed additional actions for this patient in the questionnaire.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Predictions are made for patients with the following inclusion and exclusion criteria:
Inclusion Criteria:
  • Adult patients (>18 years old)

  • Acute or elective surgery

  • Invasive or minimally invasive surgical procedures

Exclusion Criteria:
  • Outpatient procedures or procedures not requiring any form of monitoring/anesthesia

  • Procedures for which the primary indication is (treatment for) an infection

  • Radiological procedures

  • Cardiological catheterization procedures

  • Psychiatric treatment under anaesthesia (i.e. electroconvulsive therapy)

  • Sole anaesthetic procedures except for implantation of a neurostimulator

  • Brachytherapy procedures

  • Endoscopic procedures for diagnostic purposes only

  • Procedures that only entail the taking of a biopsy for diagnostic purposes

  • Patients that are pregnant

  • Procedures out of office hours (before 8.00 am or after 5.00 pm)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sesmu Arbous Leiden Zuid-holland Netherlands 2333 ZA

Sponsors and Collaborators

  • Leiden University Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sesmu M. Arbous, MD PhD MSc, Principal Investigator, Sesmu M. Arbous, MD PhD MSc, Leiden University Medical Center
ClinicalTrials.gov Identifier:
NCT05961930
Other Study ID Numbers:
  • 2022-64
First Posted:
Jul 27, 2023
Last Update Posted:
Jul 27, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2023